GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Seelos Therapeutics Inc (STU:NXE) » Definitions » Cyclically Adjusted Book per Share

Seelos Therapeutics (STU:NXE) Cyclically Adjusted Book per Share : €1,141.54 (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Seelos Therapeutics Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Seelos Therapeutics's adjusted book value per share for the three months ended in Dec. 2023 was €-25.099. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €1,141.54 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Seelos Therapeutics's average Cyclically Adjusted Book Growth Rate was -78.30% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -61.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -49.10% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -33.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Seelos Therapeutics was -18.70% per year. The lowest was -61.20% per year. And the median was -27.05% per year.

As of today (2024-05-17), Seelos Therapeutics's current stock price is €21.24. Seelos Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was €1,141.54. Seelos Therapeutics's Cyclically Adjusted PB Ratio of today is 0.02.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Seelos Therapeutics was 25.50. The lowest was 0.02. And the median was 0.51.


Seelos Therapeutics Cyclically Adjusted Book per Share Historical Data

The historical data trend for Seelos Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seelos Therapeutics Cyclically Adjusted Book per Share Chart

Seelos Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16,608.40 7,874.04 6,999.23 2,636.19 1,141.54

Seelos Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,636.19 2,604.90 1,870.10 1,177.90 1,141.54

Competitive Comparison of Seelos Therapeutics's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Seelos Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Seelos Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Seelos Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Seelos Therapeutics's Cyclically Adjusted PB Ratio falls into.



Seelos Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Seelos Therapeutics's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book= Book Value per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-25.099/129.4194*129.4194
=-25.099

Current CPI (Dec. 2023) = 129.4194.

Seelos Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201403 12,359.615 99.695 16,044.756
201406 16,450.943 100.560 21,172.253
201409 16,623.214 100.428 21,422.020
201412 2,509.677 99.070 3,278.509
201503 2,204.286 99.621 2,863.624
201506 -4,137.143 100.684 -5,317.897
201509 -10,070.000 100.392 -12,981.710
201512 -13,041.429 99.792 -16,913.251
201603 -7,145.349 100.470 -9,204.171
201606 -9,769.767 101.688 -12,434.074
201609 -6,275.701 101.861 -7,973.586
201612 -6,658.879 101.863 -8,460.291
201703 728.704 102.862 916.842
201706 3,285.955 103.349 4,114.853
201709 2,536.842 104.136 3,152.779
201712 1,750.237 104.011 2,177.793
201803 1,532.159 105.290 1,883.294
201806 1,387.423 106.317 1,688.909
201809 901.535 106.507 1,095.481
201812 576.786 105.998 704.234
201903 31.916 107.251 38.513
201906 49.301 108.070 59.041
201909 83.676 108.329 99.966
201912 -0.053 108.420 -0.063
202003 33.390 108.902 39.681
202006 17.793 108.767 21.171
202009 25.599 109.815 30.169
202012 9.303 109.897 10.956
202103 63.762 111.754 73.841
202106 161.075 114.631 181.854
202109 145.317 115.734 162.500
202112 115.408 117.630 126.975
202203 94.186 121.301 100.490
202206 56.075 125.017 58.050
202209 17.822 125.227 18.419
202212 -22.433 125.222 -23.185
202303 -38.016 127.348 -38.634
202306 -84.157 128.729 -84.609
202309 -42.878 129.860 -42.733
202312 -25.099 129.419 -25.099

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Seelos Therapeutics  (STU:NXE) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Seelos Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=21.24/1141.54
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Seelos Therapeutics was 25.50. The lowest was 0.02. And the median was 0.51.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Seelos Therapeutics Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Seelos Therapeutics's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Seelos Therapeutics (STU:NXE) Business Description

Industry
Traded in Other Exchanges
Address
300 Park Avenue, 2nd Floor, New York, NY, USA, 10022
Seelos Therapeutics Inc is a clinical-stage biotechnology company. The company is focused on developing products that address unmet needs in Central Nervous System (CNS) disorders and other rare disorders.